Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 14 | 2024 | 179 | 2.040 |
Why?
|
| Lung Neoplasms | 11 | 2023 | 1545 | 1.480 |
Why?
|
| Solitary Pulmonary Nodule | 2 | 2023 | 31 | 1.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2021 | 327 | 1.000 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2022 | 13 | 0.840 |
Why?
|
| Pulmonary Medicine | 2 | 2025 | 33 | 0.810 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 21 | 0.780 |
Why?
|
| Airway Obstruction | 2 | 2022 | 177 | 0.760 |
Why?
|
| Emphysema | 2 | 2024 | 67 | 0.650 |
Why?
|
| Ultrasonography, Interventional | 3 | 2019 | 206 | 0.640 |
Why?
|
| Pneumonectomy | 2 | 2018 | 151 | 0.570 |
Why?
|
| Biopsy, Fine-Needle | 7 | 2021 | 107 | 0.480 |
Why?
|
| Image-Guided Biopsy | 5 | 2021 | 42 | 0.450 |
Why?
|
| Lymph Nodes | 5 | 2017 | 377 | 0.440 |
Why?
|
| Lung Diseases | 2 | 2016 | 401 | 0.400 |
Why?
|
| Drainage | 3 | 2022 | 253 | 0.400 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2023 | 2123 | 0.390 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 1001 | 0.390 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 152 | 0.380 |
Why?
|
| ErbB Receptors | 1 | 2013 | 298 | 0.350 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 246 | 0.340 |
Why?
|
| Neoplasm Staging | 5 | 2021 | 1325 | 0.340 |
Why?
|
| Endosonography | 4 | 2021 | 79 | 0.330 |
Why?
|
| Pulmonary Emphysema | 2 | 2024 | 95 | 0.330 |
Why?
|
| Neoplasms | 2 | 2022 | 2965 | 0.300 |
Why?
|
| Bronchi | 3 | 2019 | 102 | 0.290 |
Why?
|
| Lung | 3 | 2023 | 1571 | 0.290 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 148 | 0.250 |
Why?
|
| Lymphatic Metastasis | 4 | 2021 | 433 | 0.240 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2017 | 30 | 0.240 |
Why?
|
| Humans | 31 | 2025 | 131967 | 0.200 |
Why?
|
| Thyroid Neoplasms | 2 | 2016 | 248 | 0.190 |
Why?
|
| Simulation Training | 1 | 2025 | 168 | 0.190 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 295 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2022 | 15 | 0.180 |
Why?
|
| Thoracentesis | 1 | 2022 | 10 | 0.180 |
Why?
|
| Thoracoscopy | 1 | 2022 | 44 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 324 | 0.180 |
Why?
|
| Education, Medical, Graduate | 1 | 2025 | 548 | 0.160 |
Why?
|
| Air | 2 | 2018 | 23 | 0.160 |
Why?
|
| Critical Care | 1 | 2025 | 681 | 0.150 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 418 | 0.150 |
Why?
|
| Bronchial Neoplasms | 1 | 2018 | 16 | 0.140 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 22 | 0.140 |
Why?
|
| Granulation Tissue | 1 | 2017 | 12 | 0.140 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2018 | 63 | 0.130 |
Why?
|
| Hemoptysis | 1 | 2017 | 22 | 0.130 |
Why?
|
| Tracheotomy | 1 | 2017 | 33 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2018 | 128 | 0.130 |
Why?
|
| Sclerotherapy | 1 | 2017 | 38 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2018 | 77 | 0.130 |
Why?
|
| Quality of Life | 3 | 2024 | 2116 | 0.130 |
Why?
|
| Varicose Veins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 32 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 650 | 0.130 |
Why?
|
| Blastomyces | 1 | 2016 | 2 | 0.130 |
Why?
|
| Blastomycosis | 1 | 2016 | 7 | 0.130 |
Why?
|
| Male | 20 | 2021 | 65357 | 0.130 |
Why?
|
| Hemangiosarcoma | 1 | 2016 | 44 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2017 | 81 | 0.120 |
Why?
|
| Lung Abscess | 1 | 2015 | 15 | 0.120 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 21 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2015 | 28 | 0.120 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 40 | 0.110 |
Why?
|
| Granuloma | 1 | 2015 | 63 | 0.110 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 69 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 78 | 0.100 |
Why?
|
| Anesthesia, General | 1 | 2015 | 128 | 0.100 |
Why?
|
| Mediastinum | 3 | 2021 | 46 | 0.100 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 126 | 0.100 |
Why?
|
| Probability | 1 | 2013 | 310 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 216 | 0.100 |
Why?
|
| Aged | 12 | 2019 | 21279 | 0.100 |
Why?
|
| Female | 15 | 2021 | 71316 | 0.100 |
Why?
|
| Endoscopy | 1 | 2014 | 284 | 0.090 |
Why?
|
| Length of Stay | 1 | 2018 | 1400 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 191 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 759 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.090 |
Why?
|
| Quinazolines | 1 | 2013 | 181 | 0.090 |
Why?
|
| Patient Preference | 1 | 2013 | 146 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2013 | 605 | 0.090 |
Why?
|
| Forced Expiratory Volume | 2 | 2024 | 176 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 803 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 403 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 298 | 0.080 |
Why?
|
| Middle Aged | 11 | 2021 | 28911 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2308 | 0.070 |
Why?
|
| Acinetobacter calcoaceticus | 1 | 2007 | 1 | 0.070 |
Why?
|
| Fungemia | 1 | 2007 | 22 | 0.060 |
Why?
|
| Endovascular Procedures | 1 | 2015 | 775 | 0.060 |
Why?
|
| Candida | 1 | 2007 | 79 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2024 | 13011 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3135 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 2148 | 0.060 |
Why?
|
| Candidiasis | 1 | 2007 | 132 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 1300 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 6922 | 0.060 |
Why?
|
| Veterans | 1 | 2017 | 1801 | 0.060 |
Why?
|
| Military Personnel | 1 | 2007 | 215 | 0.050 |
Why?
|
| Skin | 1 | 2007 | 553 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1812 | 0.050 |
Why?
|
| United States | 4 | 2025 | 11827 | 0.050 |
Why?
|
| Dyspnea | 1 | 2024 | 161 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2018 | 17703 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 1078 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 2653 | 0.050 |
Why?
|
| Learning | 1 | 2025 | 374 | 0.040 |
Why?
|
| Calibration | 1 | 2021 | 95 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5298 | 0.040 |
Why?
|
| Inhalation | 1 | 2019 | 8 | 0.040 |
Why?
|
| Antifungal Agents | 2 | 2016 | 298 | 0.040 |
Why?
|
| Curriculum | 1 | 2025 | 785 | 0.040 |
Why?
|
| Survival Rate | 2 | 2015 | 2154 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2015 | 6522 | 0.040 |
Why?
|
| Adult | 6 | 2018 | 31734 | 0.040 |
Why?
|
| Mutation | 1 | 2013 | 6200 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 2018 | 58 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2992 | 0.030 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.030 |
Why?
|
| Electrocoagulation | 1 | 2017 | 32 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 95 | 0.030 |
Why?
|
| Patient Selection | 1 | 2021 | 726 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 337 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 144 | 0.030 |
Why?
|
| Itraconazole | 1 | 2016 | 24 | 0.030 |
Why?
|
| Risk Factors | 3 | 2016 | 10998 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 254 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 157 | 0.030 |
Why?
|
| Instillation, Drug | 1 | 2015 | 6 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2016 | 101 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 598 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 364 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 710 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2015 | 5122 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2015 | 147 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2017 | 215 | 0.030 |
Why?
|
| Pleural Cavity | 1 | 2014 | 6 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 1610 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 288 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 501 | 0.030 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 215 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 663 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2014 | 150 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1406 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 544 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2226 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 838 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4961 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1916 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 10108 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3864 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 1630 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 3095 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3415 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Iraq | 1 | 2007 | 11 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3352 | 0.020 |
Why?
|
| Disease Reservoirs | 1 | 2007 | 36 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4684 | 0.020 |
Why?
|
| Warfare | 1 | 2007 | 33 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1686 | 0.020 |
Why?
|
| Drug Resistance, Fungal | 1 | 2007 | 29 | 0.020 |
Why?
|
| Candida tropicalis | 1 | 2007 | 17 | 0.020 |
Why?
|
| Candida glabrata | 1 | 2007 | 18 | 0.020 |
Why?
|
| Fluconazole | 1 | 2007 | 48 | 0.020 |
Why?
|
| Military Medicine | 1 | 2007 | 52 | 0.020 |
Why?
|
| Candida albicans | 1 | 2007 | 88 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2007 | 149 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7577 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 395 | 0.010 |
Why?
|
| Critical Illness | 1 | 2007 | 616 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 18504 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 34460 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 21008 | 0.010 |
Why?
|